FR2917966A1 - Cosmetic product useful e.g. for care of keratinous material and treating skin, comprises first composition comprising lower mono-alcohol, and second composition comprising encapsulated pigment having ruptible capsule in a medium - Google Patents

Abstract

Cosmetic product for care of keratinous material, comprises, in a medium, a first composition comprising at least an lower mono-alcohol, and a second composition comprising an encapsulated pigment having ruptible capsule, in a separated manner. An independent claim is included for a set for conditioning and distributing the composition, comprising at least two independent compartments respectively containing the compositions and fitted to distribute the two compositions in separated or mixed manner.

Description

The present invention relates to a cosmetic product more particularly

  intended for the care of keratinous material (s), for example skin. It relates in particular to a cosmetic product employing, as an active ingredient, at least one lower monoalcohol Lower monoalcohols such as ethanol may be advantageous for several reasons in the field of make-up and / or care of material (s) keratin (s). Thus, by their presence in a composition, they can in particular allow to confer during the application a feeling of freshness on the skin, especially on the skin of the face.

  Such a feeling of freshness, pleasant as such for the user, can also advantageously enable the blood circulation to be activated in the part of the skin where it is felt, particularly at the level of the eye contour which constitutes a part of the whole body. particularly vascularized. The effect of freshness accompanying the application of these lower monoalcohols has the effect of reducing puffiness and dark circles present in this part of the face (anti-edema effect), because of the high vascularity and fineness in this part of the face. The application of lower monoalcohol also advantageously makes it possible to overcome the need to apply other cooling agents such as menthol, ethyl menthane carboxamide, menthyl lactate, menthoxypropanediol on the eye contour, which are generally irritating raw materials for the eyes. In addition, the lower monoalcohols such as ethanol make it possible to solubilize active agents, in particular keratolytics, such as, for example, salicylic acid and its derivatives.

  It is also desirable to hide skin defects such as redness, blemishes and pimples. This camouflage can be, in most cases, represented by a colored effect provided by coloring substances present in the cosmetic compositions. By way of illustration of coloring substances that can be used for the manufacture of cosmetic and / or dermatological compositions, mention may especially be made of dyes, pigments, pearlescent agents, optical brighteners or fluorescent compounds.

  The coloring substances, usually used in the field of cosmetics, generally color the composition in which they are formulated. However, it may be desirable, for certain applications, for this colored effect to be apparent only on application and, in other words, for the composition to be uniformly unstained or of a white color. . Recently, a new pigment encapsulation technology has made it possible to obtain encapsulated pigments such that the color of said pigment is not homogeneously developed in the composition in which they are formulated. The encapsulated pigments only appear therein. colorful dots, giving the composition an aspect that can be described as peppered. The color develops only on application of the composition containing them on a keratinous material, after breaking of the capsule of the pigments. This technology has in particular been described in applications WO 01/35933 and US 2005/0265938.

  Unfortunately, the encapsulated pigments of this type, available today, are not stable in the presence of lower monoalcohol such as ethanol. The capsules encapsulating these pigments disintegrate in effect under the action of alcohol and release the pigments contained in these capsules, which then diffuse into the formulations, causing their coloring in mass.

  There remains therefore a need to have unstained mass or white products comprising simultaneously such encapsulated pigments and lower monoalcohols. The purpose of the present invention is precisely to propose a new mode of formulation of encapsulated pigments comprising a ruptible capsule, in particular under the action of a pressure and / or alcohol, and which makes it possible to compensate for the abovementioned disadvantages. It relates more particularly to a cosmetic product comprising at least, separately from one another, a first cosmetic composition comprising at least one lower monoalcohol, and a second cosmetic composition comprising at least encapsulated pigments comprising a ruptible capsule.

  Thus, the present invention relates to a cosmetic product for makeup and / or care of keratinous material (s) comprising, separately from each other, at least a first and a second cosmetic composition, and in wherein: the first composition comprises, in a physiologically acceptable medium, at least one lower monoalcohol, and the second composition comprises, in a physiologically acceptable medium, at least encapsulated pigments comprising a ruptible capsule. It is advantageously not colored mass or white color. For the purposes of the invention, not colored in mass means that no color is developed homogeneously within the composition. On the other hand, representative points of the pigment capsules may be included. According to one embodiment of the invention, the first composition may further comprise at least one keratolytic agent. According to another embodiment, the first composition may have a pH of less than or equal to 6 and the second composition may have a pH greater than or equal to 6. For obvious reasons, the respective pH values of the two compositions are such that their mixture possesses a value compatible with an application on a keratin material, such as the skin. The product according to the invention may in particular constitute a care product. The first and second compositions may be intended for topical application. By topical application is meant here an external application on keratin materials, and in particular the skin. The first and second compositions comprise a physiologically acceptable medium. The term "physiologically acceptable medium" means a medium that is compatible with keratin materials of human beings, that is to say the skin, the lips, the scalp, the eyelashes, the eyes, the nails and / or the hair. The first and second compositions may constitute in particular cosmetic or dermatological compositions.

  According to a particular embodiment, the first and second compositions are packaged separately from one another, but combined in a single packaging unit. According to another embodiment, the first and second compositions are packaged separately from each other in separate packaging units. The present invention also relates to a set of packaging and dispensing compositions forming a product according to the invention, said set comprising at least two independent compartments respectively comprising each of said compositions and being adjusted to the distribution of the two compositions separately or in mixture. According to an alternative embodiment, the mixture of the compositions is carried out within said assembly just before use and therefore before application to at least one keratin material. According to another variant embodiment, the mixture of the two compositions is made extemporaneously outside said assembly either on a support dedicated to the treatment, such as a cotton for example, or directly on the keratinous material to be the object of the invention. care. The keratin material to be treated may be in particular the skin of the body or of the face, and preferably the skin of the face. The cosmetic products according to the invention can be particularly useful in the field of the treatment of oily skin with imperfections. Classically, a level of sebum greater than 200 g / cm at the forehead is considered to be characteristic of oily skin. The encapsulated pigments considered according to the invention are of interest for the care of such skins in that they hide these skin imperfections. The lower monoalcohol can in turn be used as a treatment agent and / or allow the solubilization of other active agents, especially keratolytics. Such treating formulations are furthermore suitable for people with oily skin, who generally appreciate light, non-oily products which are fresh on application.

  FIRST COMPOSITION As indicated above, the first composition is characterized in that it comprises a lower monoalcohol. The first composition may especially have a pH of less than or equal to 6.5, in particular ranging from 2 to 6, preferably from 3.5 to 5.5. In the present application, the term "monoalcohol" is intended to mean a hydrocarbon compound comprising a hydroxyl function. It may especially be monoalcohol comprising 2 to 4 carbon atoms, in particular 2 to 3 carbon atoms. By way of monoalcohol which can be used according to the invention, there may be mentioned in particular ethanol or isopropanol, and preferably ethanol. The first composition may comprise from 1 to 15% by weight, preferably from 5 to 10% by weight of monoalcohol (s) lower (s) relative to its total weight. As indicated above, the first composition may further comprise at least one keratolytic agent. By keratolytic agent is meant any agent capable of removing dead cells from the stratum corneum.

  These agents are well known in the cosmetics industry and include, for example, α-hydroxy carboxylic acids such as glycolic acid, lactic acid, tartaric acid, malic acid, citric acid, mandelic acid, (3-hydroxy carboxylic acids such as salicylic acid, but also fruit acids, (3-ketocarboxylic acids, their salts, amides or esters. used in the compositions according to the invention, derivatives of salicylic acid, its salts and its esters such as those described in the patent application EP-A-0 378 936. Among these, mention may be made, in a non-limiting way , n-octanoyl-5-salicylic acid, n-decanoyl-5-salicylic acid and n-dodecanoyl-5-salicylic acid According to a preferred embodiment of the invention, the keratolytic agent may be selected from salicylic acid and n-octanoyl-5-salicylic acid The first composition may comprise from 0.1 to 4% by weight, preferably from 0.5 to 4% by weight, and preferably from 1 to 4% by weight of keratolytic agent (s) relative to the total weight of said first composition.

  The first composition may also comprise other actives, in particular other actives useful for the treatment of oily skin. By way of non-limiting illustration of these active agents with regard to oily skin, mention may be made, in particular, of the following families of compounds: 1) anti-seborrhoeic active agents The term anti-seborrhoeic active agent is understood to mean a compound capable of regulating the activity of the sebaceous glands . As anti-seborrhoeic agents that may be used according to the invention, mention may be made of: retinoic acid, benzoyl peroxide, sulfur, vitamin B6 (or pyridoxine), selenium chloride, sea fennel; mixtures of cinnamon extract, tea and octanoylglycine such as Sepicontrol A5 TEA from Seppic; - the mixture of cinnamon, sarcosine and octanoylglycine, sold in particular by the company SEPPIC under the trade name Sepicontrol A5; zinc salts such as zinc gluconate, zinc pyrrolidone carboxylate (or zinc pidolate), zinc lactate, zinc aspartate, zinc carboxylate, zinc salicylate, zinc cysteate; copper derivatives and in particular copper pidolate such as Cuivridoné from Solabia; extracts of plants of the species Arnica montana, Cinchona succirubra, Eugenia caryophyllata, Humulus lupulus, Hypericum perforatum, Mentha piperita, Rosmarinus officinalis, Salvia oficinalis and Thymus vulgaris, all sold for example by the company MARUZEN; - meadowsweet (Spiraea ulamaria) extracts, such as that sold under the name Sébonorminé by the company Silab; algae extracts laminaria saccharina such as that sold under the name Phloroginé by the company Biotechmarine; mixtures of extracts of burnet root (Sanguisorba officinalis / Poterium officinale), rhizomes of ginger (Zingiber officinalis) and cinnamon bark (Cinnamomum cassia), such as that sold under the name Sebustop by the company Solabia; linseed extracts, such as the product sold under the name Linuminé by Lucas Meyer; Phellodendron extracts such as those sold under the name Phellodendron extract BG by the company Maruzen or Oubaku liquid B by the company Ichimaru Pharcos; mixtures of argan oil, of Serenoa serrulata (saw palmetto) extract and of sesame seed extract, such as that sold under the name Regu SEB by the company Pentapharm; mixtures of extracts of willowweed, terminalia chebula, nasturtium and bioavailable zinc (microalgae), such as that sold under the name Seborilys by Green Tech; extracts of Pygeum afrianum, such as that sold under the name Pygeum afrianum sterolic lipid extract by the company Euromed; extracts of Serenoa serrulata such as those sold under the name Viapure Sabal by the company Actives International, or those sold by the company Euromed; mixtures of extracts of plantain, berberis aquifolium and sodium salicylate, such as the product sold under the name Seboclear by the company Rahn; clove extract, such as that sold under the name Clove Extract Powder by the company Maruzen; Argan oil such as that sold under the name Lipofructyl by Serobiological Laboratories; lactic protein filtrates, such as the product sold under the name Normaseb by the company Sederma; algae laminaria extracts, such as that sold under the name Laminarghané by the company Biotechmarine; oligosaccharides of algae laminaria digitata such as that sold under the name Phycosaccharide AC by the company Codif; cane sugar extracts such as the product sold under the name Policosanol by Sabinsa; Sulphonated shale oil, such as that sold under the name Ichtyol Pale by the company Ichthyol; - extracts of ulmaire (spiraea ulmaria) such as that sold under the name Cytobiol Ulmaire by the company Libiol; sebacic acid, in particular sold in the form of a sodium polyacrylate gel under the name Sebosoft by Sederma; glucomannans extracted from konjac tubers and modified with alkylsulphonate chains, such as the one sold under the name Biopol Beta by the company Arch Chemical; extracts of Sophora angustifolia, such as those sold under the name Sophora powder or Sophora extract by the company Bioland; extracts of Cinchona succirubra bark such as that sold under the name Red Bark HS by the company Alban Muller; extracts of quillaja saponaria, such as the product sold under the name Panama wood HS by Alban Muller; glycine grafted on an undecylenic chain, such as that sold under the name Lipacide UG OR by the company Seppic; the mixture of oleanolic acid and nordihydroguaiaretic acid, such as that sold in the form of a gel under the name AC.Net by Sederma; phthalimidoperoxyhexanoic acid; trialkyl citrate (C12-C13) sold under the name COSMACOL 20 ECI by the company Sasol; trialkyl citrate (C14-C15) sold under the name COSMACOL ECL by the company Sasol; 10-hydroxydecanoic acid, and in particular mixtures of 10-hydroxydecanoic acid, of sebacic acid and of 1,10-decandiol, such as that sold under the name Acnacidol BG by the company Vincience; and their mixtures. As preferred anti-seborrhoeic active agents, mention may be made of: benzoyl peroxide, vitamin B 6 (or pyridoxine), zinc salts such as zinc gluconate, zinc pyrrolidone carboxylate (or zinc pidolate), zinc lactate, zinc aspartate, zinc carboxylate, zinc salicylate, zinc cysteate; - Meadowwort extracts (Spiraea ulamaria) such as that sold under the name Sébonorminé by the company Silab; algae extracts laminaria saccharina such as that sold under the name Phloroginé by the company Biotechmarine; mixtures of extracts of burnet root (Sanguisorba officinalis / Poterium officinale), of ginger rhizomes (Zingiber officinalis) and of cinnamon bark (Cinnamomum cassia), such as that sold under the name Sebustop by the company Solabia; clove extract, such as that sold under the name Clove Extract Powder by the company Maruzen; lactic protein filtrates, such as that sold under the name Normaseb by the company Sederma; - extracts of ulmaire (spiraea ulmaria) such as that sold under the name Cytobiol Ulmaire by the company Libiol; sebacic acid, in particular sold in the form of a sodium polyacrylate gel under the name Sebosoft by Sederma; Glycine grafted on an undecylenic chain, such as that sold under the name Lipacide UG OR by the company Seppic; trialkyl citrate (C12-C13) sold under the name COSMACOL ECI by the company Sasol; trialkyl citrate (C14-C15) sold under the name COSMACOL ECL by the company Sasol; 10-hydroxydecanoic acid, and in particular mixtures of 10-hydroxydecanoic acid, of sebacic acid and of 1,10-decandiol, such as that sold under the name Acnacidol BG by the company Vincience; - and their mixtures. Preferably, the anti-seborrhoeic active agent is chosen from: zinc salts such as zinc gluconate, zinc pyrrolidone carboxylate (or zinc pidolate), zinc lactate, zinc aspartate, carboxylate zinc, zinc salicylate, zinc cysteate; and preferably zinc pyrrolidone carboxylate (or zinc pidolate) or zinc salicylate; clove extract, such as that sold under the name Clove 30 extract powder by the company Maruzen; glycine grafted on an undecylenic chain, such as that sold under the name Lipacide UG OR by the company Seppic; trialkyl citrate (Ci2-C13) sold under the name COSMACOL ECI by the company Sasol; trialkyl citrate (C14-C15) sold under the name COSMACOL ECL by the company Sasol; - and their mixtures.

  The anti-seborrhoeic active agent is for example present in a content ranging from 0.1 to 10% by weight, preferably from 0.1 to 5% by weight, and preferably from 0.5% to 3% by weight, relative to the total weight of said first composition.

  2) Anti-acne active agents In an advantageous aspect of the invention, the first composition may also comprise at least one anti-acne active agent. By anti-acne active, is meant in particular any active having effects on the specific flora of oily skin such as for example Propionibacterium acnes (P acnes). These effects can be bactericidal.

  As anti-bactericidal active agents, mention may in particular be made of: the active agents and preservatives with antimicrobial activity mentioned in the application DE10324567, incorporated in the present invention by reference, the Asian acid, the monoethanolamine salt of the 1-hydroxy- 4-methyl 6-trimethylpentyl 2-pyridone (INCI name: piroctone olamine), sold in particular under the name Octopirox by Clariant; citronellic acid, perillic acid (or 4-isopropenylcyclohex-1-enecarboxylic acid), 2-ethyl hexyl ether of glycerol (INCI name: ethylhexylglycerine), for example sold under the name Sensiva SC 50 by the Shulke & Mayr company, - caprylate / glyceryl caprate, for example sold under the name Capmul MCM by ABITEC; sodium calcium phosphosilicate, sold in particular under the names Bioactive glasspowder and Actysse Premier BG by Schott 30 Glass; silver-based particles, for example those sold under the name Metashine ME 2025 PS by the company Nippon Sheet Glass; the hop cone extract (Humulus Lupulus) obtained by supercritical CO2 extraction, such as that sold under the name HOP CO2-TO extract by the company Flavex Naturextrakte; the extract of Millepertius obtained by supercritical CO2 extraction such as that sold under the name ST John's Wort CO2-TO extract by the company Flavex Naturextrakte, - the mixture of extracts of roots of scutellaria baicalensis, of paeonia suffruticosa and of glycyrrhiza glabra, such as that sold under the name BMB-CF by the company Naturogin, 10 - argan extract such as Argapure LS9710 from COGNIS; - bearberry leaf extracts such as that sold under the name Melfade-J by Pentapharm; 10-hydroxy-2 decanoic acid, such as Acnacidol P from Vincience, sodium ursolate, azelaic acid, di-iodomethyl p-tolylsulfone, such as the Flowable Angular Friend from Angus malachite powder, zinc oxide such as Zincaré from Elementis GMBH, octadecenedioic acid such as Arlatone dioic DCA from Uniqema; ellagic acid; 2,4,4'-trichloro-2'-hydroxy diphenyl ether (or triclosan), 1- (3 ', 4'-dichlorophenyl) -3- (4'-chlorophenyl) urea (or triclocarban), on 3 4,4'-trichlorocarbanilide, 3 ', 4', 5'-trichlorosalicylanilide, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, hexamidine isethionate, metronidazole and its salts, miconazole and its salts, itraconazole , terconazole, econazole, ketoconazole, saperconazole, fluconazole, clotrimazole, butoconazole, oxiconazole, sulfaconazole, sulconazole, terbinafine, ciclopirox, ciclopiroxolamine, undecylenic acid and its salts, benzoyl peroxide, 3-hydroxy benzoic acid, 4-hydroxy benzoic acid, phytic acid, N-acetyl-L-cysteine, lipoic acid, azelaic acid and its salts, arachidonic acid, resorcinol, 3,4,4'-trichlorocarbanalide, octoxyglycerine or octoglycerine, octanoylglycine such as Lipacid C8G from Seppic, caprylyl glycol, 10-hydroxy-2-decanoic acid, dichlorophenyl imidazol dioxolan and its derivatives described in patent application WO9318743, iodopropynyl butylcarbamate, 3,7,11-trimethyldodeca-2,5,10-trienol or farnesol phytosphingosines; quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts, and mixtures thereof. Mention may also be made of certain surfactants having an antimicrobial effect such as cocoampho sodium acetate or diacetate disodium such as Miranol C2M CONC NP, betaines such as cocoyl betaine Genagen KB from Clariant, sodium lauryl ether sulfate such as Emal 270 D of Kao, decyl glucoside such as Plantacare 2000 UP, maleate of branched C12_13 dialcohols such as Cosmacol EMI, monoesters of propylene glycol such as monolaurate, monocaprylate, propylene glycol monocaprate, lauryl dimethylamine betaine such as Empigen BB / LS and quaternary polyammoniums such as Quaternium-24 or Bardac 2050 from Lonza and those described in patent FR 0 108 283 and mixtures thereof. Preferred antimicrobial agents include caprylyl glycol, octoglycerin or octoxyglycerine, 10-hydroxy-2-decanoic acid, and mixtures thereof. Other additional anti-acne active agents may be added to the aforementioned anti-acne actives. There may be mentioned in particular the active agents having bacterial anti-adhesion effects or acting on the bio film of the bacteria to prevent their multiplication. As agents that prevent and / or reduce the adhesion of microorganisms, mention may be made in particular of: phytantriol and its derivatives as described in patent application EP 1 529 523, vegetable oils such as wheat germ oil , calendula oil, castor oil, olive oil, avocado oil, sweet almond oil, peanut oil, jojoba oil, sesame oil, apricot kernel oil, sunflower oil, macadamia oil, described in patent EP 1 133 979, or certain surfactants such as disodium cocoamphodiacetate, glyceryl cocoate oxyethylenes (70E), hexadecenylsuccinate 18, octoxyglyceryl palmitate, octoxyglyceryl behenate, dioctyl adipate, PPG-15 stearyl ether, branched C12-C13 di-alcohols tartrate described in US Pat. EP 1 129 694 and mixtures thereof. In particular with regard to the propagation of P acnes, or as active agents acting on the bio-film of bacteria to prevent their proliferation, mention may be made of pentylene glycol, nylon-66 (polyamide 66 fibers), rice bran oil, polyvinyl alcohol such as Celvol 540 PV alcohol from Celanese Chemical, rapeseed oil such as Akorex L from Karlshamns, and fructose derivatives and mixtures thereof.

  The active ingredient against acne may be present in a content ranging from 0.01 to 10% by weight, preferably from 0.05 to 5% by weight relative to the total weight of said first composition.

  SECOND COMPOSITION As indicated above, the second composition is characterized in that it comprises at least encapsulated pigments comprising a ruptible capsule. It may in particular have a pH greater than or equal to 6, in particular ranging from 6 to 7.

  In the present application, the term "encapsulated pigments" means pigments which are contained in capsules constituting a shell around the pigment or pigments. The capsules can contain only one kind of pigment and therefore only one color, or several kinds of pigments. The encapsulated pigments that can be used according to the invention comprise a ruptible capsule, that is to say capable of breaking, most often under the action of a manual pressure, in particular when the composition containing them is applied to a support of the keratinous material type. As indicated above, the encapsulated pigments used according to the invention thus have the advantage of not providing a mass coloration of the composition in which they are formulated thanks to their encapsulation, while being easily released from their capsules during the application on a keratin material such as the skin. The pressure exerted during the application of the composition on the keratinous material is indeed sufficient to break the capsules, and the pigment or pigments are released, imparting color to the skin.

  Therefore, the second composition may furthermore have the characteristic of being non-colored in mass as specified above, or even be white, in which the pigment capsules may, where appropriate, with regard to their specific color intensity, be included in FIG. colored dots. The pigments which are encapsulated may be chosen from inorganic pigments and organic pigments, interferential or otherwise, surface-treated or untreated, and mixtures thereof.

  A pigment is any coloring matter insoluble in cosmetic raw materials known to those skilled in the art. They can be alone (one color) or mixed. Pigments can be any color, including yellow, black, red, brown, blue and purple.

  Mention may in particular be made, as inorganic pigments, of titanium dioxide, zirconium oxides, cerium oxides, zinc oxides, iron oxides (black, yellow or red), chromium oxides, manganese violet , ultramarine blue, chromium hydrate and ferric blue. All these pigments can be optionally surface treated.

  Among the organic pigments, mention may be made of carbon black, organic lacquer-type pigments of barium, strontium, calcium or aluminum including those subject to certification by the Food and Drug Administration (FDA) (examples D & C or FD & C) and those exempt from FDA certification as lacquers based on cochineal carmine.

  The pigments are encapsulated in capsules that must be both flexible and resistant. Thus, they must be resistant to other raw materials present in the composition but flexible enough to be able to break under pressure or shear during application to the skin and thus deliver the expected color. These capsules may be, for example, a material that may be chosen from: - jojoba esters, - polymers or copolymers of acrylic acid and / or methacrylic acid, - cellulose derivatives, such as hydroxypropyl methylcellulose, - and their mixtures.

  As pigments encapsulated by jojoba esters capsules, mention may be made, for example, of the spheres marketed by Floratech (Spheres of jojoba esters) under the names Florasomes and described in US-A-6,432,428. Examples of encapsulated pigments made of polymers or copolymers of acrylic acid and / or methacrylic acid are, for example, microcapsules based on ammonium salt copolymers of ethyl acrylate / methacrylic acid, marketed by the Tagra company and described in WO-A-01/35933.

  Examples of cellulose-capsule-encapsulated pigments are spheres comprising mannitol, cellulose, hydroxypropyl methylcellulose, sold by Induchem. It is also possible to use in the same composition several kinds of capsules containing encapsulated pigments and made of different encapsulation materials. The capsules may, in addition to the pigments, contain additives such as, for example, plasticizers and / or opacifying agents so that the color of the encapsulated pigments is, for example, attenuated. The size of these capsules, i.e., their average number diameter, can range, for example, from 20 to 700 m. The percentage of pigments relative to the total weight of the encapsulated pigment (weight of the encapsulated pigment = weight of the capsule + weight of the pigments) can vary to a large extent. The amount of pigment may range, for example, from 10 to 80% by weight, preferably from 20 to 60% by weight and more preferably from 20 to 50% by weight, based on the total weight of the encapsulated pigment. The second composition may comprise an amount of encapsulated pigments (weight of the capsule + weight of the pigments) ranging, for example, from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight, preferably from 0, From 5 to 15% by weight, preferably from 0.05 to 10% by weight, for example from 0.1 to 10%, or even from 0.1 to 7% by weight, in particular from 0.1 to 5% by weight; , or even 0.1 to 4%, or even 0.1 to 2%, or even more than 2% by weight, relative to the total weight of said second composition.

  PHYSIOLOGICALLY ACCEPTABLE MEDIUM The compositions according to the invention may be in any of the galenical forms conventionally used for topical application, and especially in the form of aqueous or hydroalcoholic solutions, oil-in-water (O / W) emulsions or water in oil (W / O) or multiple (triple: W / O / W or W / O / H), aqueous gels, dehydrated anhydrous products, or dispersions of an oily phase in an aqueous phase using spherules, these spherules possibly being polymeric nanoparticles such as nanospheres and nanocapsules, or lipid vesicles of ionic (liposome) and / or nonionic type. These compositions are prepared according to the usual methods.

  In addition, the compositions according to the invention may be more or less fluid and have the appearance of a cream, an ointment, a milk, a lotion, a serum, a paste, of a foam. They may also be in solid form, for example in the form of a cast-on stick.

  According to a preferred embodiment, a composition may be in the form of an emulsion or an emulsified gel.

  When the composition according to the invention is an emulsion, it comprises an oily phase. This preferably contains at least one oil, in particular a physiologically acceptable oil. It may also contain other fatty substances. As oils that can be used in the composition of the invention, mention may be made, for example, of: hydrocarbon-based oils of animal origin, such as perhydrosqualene; hydrocarbon-based oils of vegetable origin, such as liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, castor oil, avocado, triglycerides of caprylic / capric acids such as those sold by Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by Dynamit Nobel, jojoba oil, shea butter oil; esters and synthetic ethers, in particular of fatty acids, such as the oils of formulas R'COOR2 and R'OR2 in which R 'represents the residue of a fatty acid containing from 8 to 29 carbon atoms, and R2 represents a hydrocarbon chain, branched or unbranched, containing from 3 to 30 carbon atoms, for example Purcellin oil, isononyl isononanoate, isopropyl myristate, 2-ethylhexyl palmitate, octyl-2-dodecyl stearate, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, heptanoates, octanoates, decanoates of fatty alcohols; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters such as pentaerythrityl tetraisostearate; linear or branched hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam oil; fatty alcohols having from 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and mixtures thereof (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol, 2-hexyldecanol and 2-undecylpentadecanol, oleic alcohol or linoleic alcohol; partially fluorinated hydrocarbon oils and / or silicone oils such as those described in document JP-A-2-295912; silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyldimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes; - their mixtures.

  By hydrocarbon oil is meant in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups. The other fatty substances that may be present in the oily phase are, for example, fatty acids containing from 8 to 30 carbon atoms, such as stearic acid, lauric acid, palmitic acid and oleic acid; waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, lignite waxes or microcrystalline waxes, ceresin or ozokerite, synthetic waxes such as polyethylene waxes, waxes Fischer-Tropsch; silicone resins such as trifluoromethyl-C 1-4 alkyl dimethicone and trifluoropropyldimethicone; and silicone elastomers such as the products sold under the names KSG by the company Shin-Etsu, under the names Trefil, BY29 or EPSX by the company Dow Corning or under the names Gransil by the company Grant Industries. These fatty substances may be chosen in a varied manner by those skilled in the art in order to prepare a composition having the desired properties, for example of consistency or texture. The emulsions generally contain at least one emulsifier chosen preferably from amphoteric, anionic or nonionic emulsifiers, used alone or as a mixture. The emulsifiers are suitably selected according to the continuous phase of the emulsion to be obtained (W / O or O / W). When the emulsion is multiple, it generally comprises an emulsifier in the primary emulsion and an emulsifier in the external phase into which the primary emulsion is introduced. As emulsifiers that can be used for the preparation of W / O emulsions, mention may be made, for example, of alkyl esters or ethers of sorbitan, of glycerol or of sugars; silicone surfactants such as dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the names DC 5225C and DC 3225C by the company Dow Corning, and as alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name Dow Corning 5200 Formulation Aid by Dow Corning, Cetyl dimethicone copolyol sold under the name Abil EM 90R by the company Goldschmidt and the mixture of Polyglyceryl-4 isostearate / Cetyl dimethicone copolyol / Hexyl laurate sold under the name Abil WE 09R by the company Goldschmidt. One or more coemulsifiers may also be added, which advantageously may be selected from the group consisting of branched chain fatty acid esters and polyol, and in particular the branched chain fatty acid esters and glycerol and / or sorbitan and for example polyglyceryl isostearate, such as the product sold under the name Isolan GI 34 by the company Goldschmidt, the sorbitan isostearate, such as the product sold under the name Arlacel 987 by the ICI company, sorbitan isostearate and glycerol, such as the product sold under the name Arlacel 986 by the company ICI, and mixtures thereof.

  As emulsifiers that can be used for the preparation of O / W emulsions, mention may be made, for example, of nonionic emulsifiers such as esters of fatty acids and oxyalkylenated polyols (more particularly polyoxyethylenated), and for example polyethylene glycol stearates such as stearate. PEG-100, PEG-50 stearate and PEG-40 stearate; and their mixtures; esters of oxyalkylenated fatty acids and of sorbitan comprising, for example, from 20 to 100%, and for example those marketed under the trade names TWEEN by Uniqema; oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated) such as ceteareth-20; sugar esters, especially sucrose esters such as sucrose stearate and sucrose tristearate such as Tegosoft from Degussa, and glucose esters such as methylglucose sesquistearate such as Glucate SS from Noveon; and mixtures of these emulsifiers, for example the mixture of glyceryl mono-stearate and polyethylene glycol stearate (100 OE) sold under the name Simulsol 165 by the company Seppic and the mixture of glyceryl stearate and PEG-stearate. 100, marketed under the name ARLACEL 165 by Uniqema. Co-emulsifiers such as, for example, fatty alcohols containing from 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and mixtures thereof (cetearyl alcohol), octyl dodecanol, may be added to these emulsifiers. 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol or oleic alcohol. It is also possible to prepare emulsions without emulsifying surfactants or containing less than 0.5% of the total weight of the composition, by using suitable compounds, for example polymers having emulsifying properties such as the modified carboxyvinyl polymers marketed under the names Carbopol. 1342 and Pemulen by the company Noveon; polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid (AMPS), optionally cross-linked and / or neutralized, such as poly (2-acrylamido-2-methylpropanesulphonic acid) marketed by Clariant under the name Hostacerin AMPS (name CTFA: ammonium polyacryldimethyltauramide) or as the emulsion polymer sold under the name Sepigel 305 by the company Seppic (INCI name: polyacrylamide / C13-C14 isoparaffin / laureth-7) or the copolymers of AMPS with a hydrophobic chain marketed by the company Clariant company under the names Aristoflex; ionic or nonionic polymer particles, more particularly anionic polymer particles such as in particular isophthalic acid or sulfoisophthalic acid polymers, and in particular phthalate / sulfoisophthalate / glycol copolymers (for example diethylene glycol / phthalate / isophthalate / 1,4-cyclohexanedimethanol (INCI name: Diglycol / CHDM / I sophthalates / SIP Copolymer) sold under the names Eastman AQ polymer (AQ35S, AQ38S, AQ55S, AQ48 Ultra) by the company Eastman Chemical.

  It is also possible to prepare emulsifier emulsions stabilized with silicone particles or with metal oxide particles such as TiO 2. In known manner, the composition of the invention may also contain adjuvants customary in the cosmetic or dermatological field, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives (for example phenoxyethanol and parabens), antioxidants, solvents, perfumes, fillers, UV filters, bactericides, odor absorbers, dyestuffs, salts, polymers. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01 to 20% of the total weight of the composition. These adjuvants, depending on their nature, can be introduced into the fatty phase, into the aqueous phase and / or into the lipid spherules. Of course, one skilled in the art will take care to choose the optional additive (s) to be added to the composition according to the invention and their amounts, in such a way that the advantageous properties intrinsically attached to the composition according to the invention are not not, or not substantially, impaired by the intended addition.

  As fillers which can be used in the composition of the invention, mention may be made, for example, of silica powder; talcum; polyamide particles and in particular those sold under the name ORGASOL by the company Atochem; polyethylene powders; powders of natural organic materials, such as starch powders, especially corn starch, wheat or rice, crosslinked or otherwise, such as starch powders crosslinked with octenylsuccinate anhydride, sold under the name DRY-FLO by National Starch; micro-spheres based on acrylic copolymers, such as those made of ethylene glycol dimethacrylate / lauryl methacrylate copolymer sold by Dow Corning under the name Polytrap; expanded powders such as hollow microspheres and in particular the microspheres sold under the name Expancel by the company Kemanord Plast or under the name Micropearl F 80 ED by the company Matsumoto; silicone resin microbeads such as those sold under the name Tospearl by the company Toshiba Silicone; and their mixtures. These fillers may be present in amounts ranging from 0 to 20% by weight and preferably from 1 to 10% by weight relative to the total weight of the composition. As polymers, one or more hydrophilic or lipophilic gelling agents may be incorporated in particular in the composition according to the invention. The hydrophilic gelling agents may be chosen, for example, from carboxyvinyl polymers such as the carbomers sold under the names Carbopol by the company Noveon; modified carboxyvinyl polymers such as those sold under the names Carbopol 1342 and Pemulen by Noveon; polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid (AMPS), optionally cross-linked and / or neutralized, such as poly (2-acrylamido-2-methylpropanesulphonic acid) marketed by Clariant under the name Hostacerin AMPS (name CTFA: ammonium polyacryldimethyltauramide) or as the emulsion polymer sold under the name Sepigel 305 by the company Seppic (INCI name: polyacrylamide / C13-C14 isoparaffin / laureth-7) or the copolymers of AMPS with a hydrophobic chain marketed by the company Clariant company under the names Aristoflex; polysaccharides such as gums and especially xanthan gum. These gelling agents may be present in an amount ranging, for example, from 0.001% to 10% by weight, preferably from 0.01% to 5% by weight and better still from 0.05% to 3% by weight, relative to the total weight of the composition. . As active agents, mention may be made, for example: moisturizing agents such as, for example, sodium lactate; polyols, such as glycerine, sorbitol, polyethylene glycols; mannitol; amino acids; hyaluronic acid; lanolin; urea and mixtures containing urea, such as NMF (Natural Moisturizing Factor); petrolatum; N-lauroyl pyrrolidone carboxylic acid and its salts; essential fatty acids; essential oils ; hydroxyalkyl ureas such as N- (2-hydroxyethyl) urea marketed under the name Hydrovance of the company National Starch, and mixtures thereof. anti-aging and anti-wrinkle active agents, and more particularly ahydroxy acids and in particular acids derived from fruits, such as glycolic, lactic, malic, citric, tartaric and mandelic acids, their derivatives and mixtures thereof; β-hydroxy acids such as salicylic acid and its derivatives such as n-octanoyl-5-salicylic acid or n-dodecanoyl-5-salicylic acid; α-ketoacids such as ascorbic acid or vitamin C, and its derivatives such as its salts such as sodium ascorbate, magnesium or sodium ascorbyl phosphate; its esters such as ascorbyl acetate, ascorbyl palmitate and ascorbyl propionate, or its sugars such as glycosylated ascorbic acid, and mixtures thereof; (3-keto acids, retinoids such as retinol (vitamin A) and its esters, retinal, retinoic acid and its derivatives, and the retinoids described in documents FR-A-2,570,377, EP-A- 199636, EP-A-325540, EP-A-402072, adapalene, carotenoids, C-glycoside derivatives such as CBD-xylopyranoside-n-propan-2-one, especially CBD-xylopyranoside-n-propane- 2-one in the form of a 30% solution of active ingredient in a water / propylene glycol mixture (60/40% by weight) manufactured by the company Chimex under the trade name MEXORYL SBB; vitamins, such as vitamins A and C indicated above, and also as vitamin E (tocopherol) and its derivatives, vitamin B3 (or vitamin PP or niacinamide) and its derivatives, vitamin B5 (or panthenol in its various forms: D-panthenol, DL-panthenol) , and its derivatives and the like, such as calcium panthotenate, panthetin, pantothin, diethyl ether, panthenyl thyl, pangamic acid, pyridoxine, pantoyl lactose, and natural compounds containing it such as royal jelly; vitamin D and its analogs such as those described in WO-A-00/26167; vitamin F or its analogs such as unsaturated acid mixtures having at least one double bond and especially mixtures of linoleic acid, linolenic acid and arachidonic acid, or compounds containing them; antibacterials and anti-seborrhoeics such as salicylic acid, 2,4,4'-trichloro-2'-hydroxy diphenyl ether (or triclosan), 3,4,4'-trichlorobanilide (or triclocarban), azelaic acid, benzoyl peroxide and zinc salts such as lactate, gluconate, pidolate, carboxylate, salicylate and / or zinc cysteate. Examples of organic filters that may be mentioned are the following families: anthranilates, in particular menthyl anthranilate; benzophenones, in particular benzophenone-1, benzophenone-3, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, and preferentially benzophenone-2 (oxybenzone), or Benzophenone-4 (Uvinul MS40 marketed by BASF); benzylidenecamphers, in particular 3-benzylidene camphor, benzylidenecamphosulfonic acid, camphor benzalkonium methosulphate, polyacrylamidomethylbenzylidene camphor, terephthalylidene di-camphorsulfonic acid, and 4-methylbenzylidene camphor (Eusolex 6300 sold by Merck); benzimidazoles, in particular benzimidazilate (Neo Heliopan AP marketed by Haarmann and Reimer), or phenylbenzimidazole sulfonic acid (Eusolex 232 marketed by Merck); benzotriazoles, in particular trisiloxane drometzol, or methylene bis-benzotriazolyltetramethylbutylphenol (Tinosorb M marketed by Ciba); cinnamates, in particular cinoxate, DEA methoxycinnamate, diisopropyl methylcinnamate, dimethoxycinnamate glyceryl ethylhexanoate, isopropyl methoxycinnamate, isoamyl cinnamate, and preferably ethocrylene (Uvinul N35 sold by BASF), octyl methoxycinnamate (Parsol MCX marketed by Hoffmann La Roche), or octocrylene (Uvinul 539 marketed by BASF); dibenzoylmethanes, especially butyl methoxydibenzoylmethane (Parsol 1789); imidazolines, in particular ethylhexyl dimethoxybenzylidene dioxoimidazoline; PABA, in particular ethyl dihydroxypropyl PABA, ethylhexyldimethyl PABA, glyceryl PABA, PABA, PEG-25 PABA, and preferentially diethylhexylbutamido-triazone (Uvasorb HEB marketed by 3V Sigma), ethylhexyltriazone (Uvinul T150 marketed by BASF), or ethyl PABA (benzocaine); salicylates, especially dipropylene glycol salicyclate, ethylhexyl salicylate, homosalate, or TEA salicylate; triazines, in particular anisotriazine (Tinosorb S marketed by Ciba); drometrizole trisiloxane. The amount of filters depends on the desired end use. It may range, for example, from 1 to 20% by weight and better still from 2 to 10% by weight relative to the total weight of the composition.

  PACKAGING ASSEMBLY As previously stated, the invention also relates to a packaging assembly. More particularly, this set comprises at least: i. a first compartment containing a first composition comprising, in a physiologically acceptable medium, at least alcohol, and ii. a second compartment containing a second composition and comprising, in a physiologically acceptable medium, at least encapsulated pigments comprising a ruptible capsule, said second compartment being sealed from the first, and iii. means for allowing the contacting, in particular extemporaneous, of the two compositions. Such a set advantageously allows the extemporaneous contact of its two compositions, separately packaged respectively in the first and second compartments forming said assembly.

  The alcohol is advantageously a lower monoalcohol. This set may also be provided with means for placing in communication the first and second compartments, and therefore their respective contents. The assembly is also advantageously provided with a means conducive to the distribution of the mixture of the two compositions.

  More specifically, the first and second compositions used for the implementation of the invention are packaged separately inside two compartments, formed either by two separate containers, or inside a unitary device. According to one embodiment, the two compartments may be formed of two concentric compartments formed inside a tube. By unitary device is meant a device by which the two compartments are integral with each other. Such a device can be obtained by a method of molding in one piece of the two compartments, in particular a thermoplastic material. It may also result from any form of assembly, especially by gluing, welding, or other snapping. According to a first embodiment, the two containers are independent of one another. Such containers may be in various forms. This may include tubes, bottles or cans. One and / or the other of the containers may be surmounted by a manually operated pump surmounted by a push button for actuating the pump and dispensing the composition via at least one dispensing orifice.

  Alternatively, one and / or the other of the containers are pressurized, in particular by means of a propellant, in particular a propellant. In this case, the (or) container (s) is (are) equipped with a valve surmounted by a push button equipped with a nozzle or other means of diffusion for the distribution of the product.

  The propellant may be in admixture with the composition to be dispensed or separated, in particular via a piston able to slide inside the container, or via the flexible walls of a pocket inside which the composition is arranged. The containers may be made of various materials: plastic, glass, or metal.

  According to a preferred embodiment, the two compositions are contained within a unitary device. According to the embodiment shown in Figure 1, the packaging device 1 consists of two compartments 51, 52 arranged side by side and formed inside a molded part 5 obtained from a thermoplastic material. Each of the containers 51, 52 has a neck 53 defining an opening.

  Inside the neck of each of the containers is mounted a pump 41, 42, which can be with or without air intake. During assembly, the part 5 delimiting the two compartments 51, 52 is disposed inside a covering element 10.

  A pump rod 21a, 22a, of each of the pumps 41, 42 is forced into a corresponding conduit provided in a single push button 3 configured to allow simultaneous actuation of the two pumps, in response at a pressure exerted axially on a surface 35 of the push button 3. The push button conduits connected to each of the pumps open on two orifices 31a, 32a disposed in the vicinity of each other on an outer surface of the push button 3 In response to actuation of the pumps 41, 42, the two compositions exit separately either on the user's finger or on a tampon or cotton applicator. The mixture of the two compositions is then made during application to the surface to be treated.

  According to another embodiment not illustrated, the two containers are pressurized and equipped with a valve depression or tilt. The two valves are preferably operable by the same push button of the type described with reference to the pump embodiment. Alternatively, the two compartments are formed of two concentric compartments formed inside a tube, and where appropriate are surmounted by a pump without air intake equipped with a pushbutton to one or two distribution ports . Inside the tube may be provided a piston that goes up towards the pump as the compositions are taken from the inside of the containers. Such modes of distribution are used in particular for the distribution of toothpastes.

  Still other devices can be used for the practice of the present invention, the essential being that they can allow the separate packaging of the two compositions and their distribution separately or in mixture. By way of example, the two compositions are packaged inside two compartments formed inside a single flexible bag, the two compartments being separated by a rupture zone which can be broken at the moment of use. , in particular in response to pressure exerted at a specific location of the bag. The invention therefore relates in particular to an assembly, wherein the first and second compositions are packaged inside two compartments formed by two separate containers.

  According to one particular embodiment, the first and second compositions are packaged inside two compartments (51, 52) delimited by a unitary device (1) as represented in FIG. 1. In particular, each of the compartments is equipped with a pump (41, 42), preferably manually operated, connected to at least one actuating and dispensing means (3) for delivering, separately or in mixture, the first and second compositions. According to a preferred embodiment, the actuating and dispensing means (3) is common to both pumps. According to an alternative, each of the compartments is pressurized, in particular by means of a propellant, and equipped with a valve connected to at least one actuating and dispensing means making it possible to deliver, separately or as a mixture, the first and second compositions .

  In particular, the actuating and dispensing means is common to both valves. For example, devices as described in US 5,833,121, US 4,773,562 and US 6,672,483 may be used.

  An assembly or a product according to the invention is more particularly intended for a cosmetic application of the care type. The products according to the invention may in particular constitute skincare products (body, face, eyes), scalp and / or hair, preferably skin.

  Another subject of the invention consists in the cosmetic use of a product as defined above, as care products for the skin, the scalp and / or the hair, preferably the skin. The products according to the invention may together constitute a product for treating oily skin and / or disinfecting the skin and / or the scalp, especially when they contain an antibacterial agent. The examples which follow serve to illustrate the invention without, however, being limiting in nature. The quantities indicated are in% by weight of raw material (and not of active ingredient) unless otherwise stated.

  EXAMPLES Example 1: First composition containing the monoalcohol

  PHASE I - Water qs 100% 25 - Glycerin 7.00% - Preservatives 0.95% - Triethanolamine 0.90%

  PHASE II 30 - Salicylic acid 0.60% - Water 0.20% PHASE III - Mixture of glyceryl stearate and PEG-100 stearate (ARLACEL 165 FL from Uniqema) 0.15% - Cyclohexasiloxane 6.00% 5 - 0.25% cetyl alcohol PHASE IV - Polyacrylamidomethyl propanesulfonic acid partially neutralized with ammonia and highly crosslinked (Hostacerin AMPS from Clariant) 1.50% - Cyclohexasiloxane 6.50% PHASE V - Ethanol 5.00% PHASE VI - nylon powder 3.00%

  Procedure: Phase I and III are separately heated to 75-80 ° C. Phase III is added to Phase I and the mix is mixed. Once the emulsion has been formed, phases II and IV are added at 60 ° C. Phase V and VI are then added at room temperature. The composition thus obtained has a pH of about 5.6.

  EXAMPLE 2 First Composition Containing Monoalcohol Phase I-Triethanolamine 1.04% Preservative qs Water qs 100% Glycerin 7.00%

  Phase II - 0.25% Cetyl Alcohol - Dimethicone - (DOW CORNING 200 FLUID 100 CST from Dow Corning) 2.00% - Mixture of glyceryl stearate and PEG-100 stearate (ARLACEL 165 FL from Uniqema) 0 Phase III - Polymer ACRYLIC ACID / ALKYL ACRYLATE CROSSLINKED - (Pemulen TR 2 from Noveon) 0.20% - Polyacrylamidomethyl propanesulfonic acid partially neutralized with ammonia and highly crosslinked (Hostacerin AMPS from Clariant) ) 1.50%

  Phase IV - Fragrance 15 - Cyclohexasiloxane

  Phase V - Nylon Powder - Salicylic Acid 20 - Ethanol

  Procedure: Phase I is heated to 75 C. Phase II is also heated to 75/80 C. The emulsion is carried out at 65 ° C. with vigorous stirring by pouring phase II into phase I. The whole is then thickened by adding phase III. Around 50 C phase IV is added. Once the temperature has fallen to 25/30 C, phase V is added and salicylic acid and denatured alcohol previously solubilized together. Example 3: Second composition containing encapsulated peppers Phase I - Octyldodecanol 4.00% - Isononyl isononyl ester 2.00% - Cyclohexasiloxane 2.50% 0.40% 10.50%

  2.50% 2.00% 10.00% - Cetearyl alcohol 0.30% - Ceralutiori H from Sasol 3.80% (ie about 0.75% MA sodium Sodium dicocoyl-ethylenediamine PEG-15) Phase II - Preservatives qs - Water qs 100% - Butylene glycol 3.00% Phase III - Silicone thickener 7.00% - Sodium hydroxide 0.05% Nylon powder 1.20% - Encapsulated yellow iron oxides sold under the name 0, 60% YELLOWCAP1by TAGRA Biotechnologies - Encapsulated red iron oxides sold under the name 0.40% REDCAP1 by the company TAGRA Biotechnologies - Encapsulated black iron oxides sold under the name 0.01% BLACKCAP1 by the company TAGRA Biotechnologies - Starch maize esterified with octenylsuccinic anhydride, 0.50% aluminum salt (Dry Flo Plus from National Starch) - 0.15% xanthan gum - Polyacrylamidomethyl propanesulfonic acid neutralized 1.20% partly with ammonia and highly crosslinked ( Hostacerin AMPS from Clariant) - Glycerin 7.00% Procedure: Phase I is heated to 75-80 C. Phase II is also heated to this temperature before being added to phase I. Their mixture is mixed. Once the emulsion is formed, phase III is added and the mixture is then mixed. Hostacerin AMPS gels and xanthan gum are added. The whole is neutralized with sodium hydroxide. At room temperature, encapsulated fillers and pigments are added. The composition thus obtained has a pH of 6.5.

  The composition of Example 1 or 2 is mixed with the composition of Example 3 in a 50/50 volume ratio. The mixture thus obtained is applied to oily skin conferring a treating, refreshing and astringent effect, while masking skin imperfections such as pimples.

  EXAMPLE 4 First composition containing the monoalcohol A product was prepared for the eye contour having the following composition: Algae extract 0.20 g Isohexadecane 5, 50 g Polyamide powder 0.50 g Carboxyvinyl polymer (Carbopol 981 from Noveon) 0.15 g - Polyacrylamidomethyl propane sulfonic acid partially neutralized with ammonia and highly crosslinked (Hostacerin AMPS from Clariant) - Silicone thickener - Ethanol - water 25 - Glycerine - Propylene glycol - preservatives

  The composition of Example 4 is mixed with the composition of Example 3 at a 50:50 volume ratio. The mixture thus obtained is applied on the eye contour and gives a cooling effect and blur dark circles. 1.80 g 16.50 g 5 g qs 100 g 5 g 6.60 g qs

Claims (22)

  1. Cosmetic care product of keratin material (s) comprising, separately from one another, at least a first and a second cosmetic composition, and wherein: the first composition comprises, in a physiologically acceptable medium, at least one lower monoalcohol, and the second composition comprises, in a physiologically acceptable medium, at least encapsulated pigments comprising a ruptible capsule.   2. Product according to the preceding claim, wherein the first composition further comprises at least one keratolytic agent.   3. Product according to any one of the preceding claims, wherein the pigments are chosen from inorganic pigments and organic pigments, interferential or not, surface-treated or untreated, and mixtures thereof.   A product according to any one of the preceding claims wherein the pigments are encapsulated in capsules which are of a material selected from jojoba esters, polymers or copolymers of acrylic acid and / or methacrylic acid, cellulose derivatives, and mixtures thereof.   5. Product according to the preceding claim, characterized in that the capsules have a size ranging from 20 to 700 m.   6. Product according to any one of the preceding claims, wherein the pigments are present in an amount ranging from 10 to 80% by weight relative to the total weight of the encapsulated pigment.   7. A product according to any one of the preceding claims, wherein the second composition comprises an amount of encapsulated pigments ranging from 0.01% to 20% by weight, preferably from 0.05 to 15% by weight, for example from 0 to 15% by weight. , 1 to 10% by weight, or even 0.1 to 2% by weight, relative to the total weight of said second composition.   8. Product according to any one of claims 2 to 7, wherein the keratolytic agent is selected from α-hydroxy carboxylic acids such as glycolic acid, lactic acid, tartaric acid, malic acid. citric acid, mandelic acid, (3-hydroxy carboxylic acids such as salicylic acid, but also fruit acids, (3-ketocarboxylic acids, their salts, amides or esters.   9. Product according to any one of claims 2 to 8, wherein the keratolytic agent is selected from salicylic acid, its salts and esters.   The product according to any one of claims 2 to 9, wherein the first composition comprises from 0.1 to 4% by weight, preferably from 0.5 to 4% by weight of keratolytic agent (s). ) relative to the total weight of said first composition.   11. Product according to any one of the preceding claims, wherein the monoalcohol is ethanol or isopropanol.   12. Product according to any one of the preceding claims, wherein the first composition comprises from 1 to 15% by weight, preferably from 5 to 10% by weight of monoalcohol (s) lower (s) relative to the total weight of said first composition.   13. Product according to any one of the preceding claims, wherein the first composition has a pH of less than or equal to 6, in particular ranging from 2 to 6, preferably from 3.5 to 5.5.   14. Product according to any one of the preceding claims, wherein the second composition has a pH greater than or equal to 6, in particular ranging from 6 to 7.   15. A product according to any one of the preceding claims, wherein the first and second compositions are in the form of an emulsion or an emulsified gel.   16. A product according to any one of the preceding claims, wherein the first and second compositions are packaged separately from one another, but combined in a single package.   The product of any one of claims 1 to 15, wherein the first and second compositions are packaged separately from each other in separate packaging units.   18. A packaging and dispensing assembly of the compositions forming a product according to any one of claims 1 to 17, said assembly comprising at least two independent compartments respectively comprising each of said compositions and being adjusted to the distribution of the two compositions separately or in mixture.   19. Assembly according to the preceding claim, wherein the mixture of said compositions is carried out within said assembly just before application to at least one keratin material.   20. The assembly of claim 18, such that the mixture of said two compositions is made extemporaneously outside said assembly either on a support dedicated to care, or directly on the keratin material to be the object of care.   21. An assembly according to any one of claims 18 to 20 wherein the first and second compositions are packaged separately within two compartments formed by two separate containers.   22. An assembly according to any one of claims 18 to 21, wherein the two compartments are formed of two concentric compartments formed inside a tube.